IONQ-WT · IonQ, Inc. — research history

The investigation trigger was a reported cluster of 3 Form 4 filings in the last 14 days. However, after reading every filing text, all transactions were RSU vesting events (code 'A' at $0), not open-market purchases. The two director sales on June 17-18 were executed via Rule 10b5-1 pre-planned trading plans adopted months earlier (September 2025 and March 2026) — not discretionary buys or sells. There is zero evidence of any insider purchasing common stock or warrants in the open market during the review window. Additionally, IONQ-WT has NO listed options chain, making it ineligible for option structure strategies. The underlying common (IONQ) has valid catalysts including an active FTC HSR review on the SkyWater merger and upcoming Q2 earnings Aug 5, but this warrant vehicle cannot be traded via any standard structure.

The investigation trigger was met (4 Form 4s in 14 days), but all four filings from June 12, 2026 were routine RSU vesting tax-withholding sales by the CEO ($906K), CFO ($352K), CAO ($231K) and an executive chair ($51K). Code F = automatic tax selloff on RSU delivery — NOT open-market purchases. Zero open-market P/S (voluntary purchase) transactions appear in the last 90 days of Form 4 filings. The trigger is a false positive: insiders are not buying, they are selling shares that vest automatically. IONQ trades at an absurd forward P/E of -55x with massive FCF burn ($91M trailing), yet has rallied ~125% YTD on quantum computing hype and CHIPS Act funding speculation. A recent Martin Shkreli controversy accused IonQ of exaggerating quantum capabilities, adding reputational risk. The company was notably excluded from the US government quantum funding program alongside Google and Microsoft. No mispricing exists — IONQ is richly speculative at best.